193 related articles for article (PubMed ID: 23299341)
1. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G
Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341
[TBL] [Abstract][Full Text] [Related]
2. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.
Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ
J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
4. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
Eisenhofer G; Goldstein DS; Walther MM; Friberg P; Lenders JW; Keiser HR; Pacak K
J Clin Endocrinol Metab; 2003 Jun; 88(6):2656-66. PubMed ID: 12788870
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma.
Bisschop PH; Corssmit EP; Baas SJ; Serlie MJ; Endert E; Wiersinga WM; Fliers E
Neth J Med; 2009 Mar; 67(3):91-5. PubMed ID: 19307679
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB
J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397
[TBL] [Abstract][Full Text] [Related]
8. [Test with clonidine for diagnosing pheochromocytoma].
Wocial B; Chojnowski K; Chodakowska J; Feltynowski T; Lazecki D; Januszewicz W
Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):641-5. PubMed ID: 1845684
[TBL] [Abstract][Full Text] [Related]
9. Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytoma.
Pamporaki C; Bursztyn M; Reimann M; Ziemssen T; Bornstein SR; Sweep FC; Timmers H; Lenders JW; Eisenhofer G
Eur J Endocrinol; 2014 Mar; 170(3):349-57. PubMed ID: 24497497
[TBL] [Abstract][Full Text] [Related]
10. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients.
Václavík J; Stejskal D; Lacnák B; Lazárová M; Jedelský L; Kadalová L; Janosová M; Frysák Z; Vlcek P
J Hypertens; 2007 Jul; 25(7):1427-31. PubMed ID: 17563565
[TBL] [Abstract][Full Text] [Related]
11. [Biological diagnosis of pheochromocytoma: impact of technological improvement].
Peyrin L; Mornex R
Ann Biol Clin (Paris); 1993; 51(10-11):835-65. PubMed ID: 8210060
[TBL] [Abstract][Full Text] [Related]
12. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
Goupil R; Fountoulakis S; Gordon RD; Stowasser M
J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
[TBL] [Abstract][Full Text] [Related]
13. How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines.
Roden M
Wien Klin Wochenschr; 2002 Apr; 114(7):246-51. PubMed ID: 12089859
[TBL] [Abstract][Full Text] [Related]
14. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
[TBL] [Abstract][Full Text] [Related]
15. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
[TBL] [Abstract][Full Text] [Related]
16. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma.
Eisenhofer G; Lattke P; Herberg M; Siegert G; Qin N; Därr R; Hoyer J; Villringer A; Prejbisz A; Januszewicz A; Remaley A; Martucci V; Pacak K; Ross HA; Sweep FC; Lenders JW
Ann Clin Biochem; 2013 Jan; 50(Pt 1):62-9. PubMed ID: 23065528
[TBL] [Abstract][Full Text] [Related]
17. An audit of management of patients with borderline increased plasma-free metanephrines.
Anas SS; Vasikaran SD
Ann Clin Biochem; 2010 Nov; 47(Pt 6):554-8. PubMed ID: 20926470
[TBL] [Abstract][Full Text] [Related]
18. Multicenter study on the diagnostic value of a new RIA for the detection of free plasma metanephrines in the work-up for pheochromocytoma.
Lenz T; Zorner J; Kirchmaier C; Pillitteri D; Badenhoop K; Bartel C; Geiger H; Hasselbacher K; Tuschy U; Westermann J; Salewski L
Ann N Y Acad Sci; 2006 Aug; 1073():358-73. PubMed ID: 17102105
[TBL] [Abstract][Full Text] [Related]
19. The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls.
Sjoberg RJ; Simcic KJ; Kidd GS
Arch Intern Med; 1992 Jun; 152(6):1193-7. PubMed ID: 1599347
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
